Downshifting Luminescence Rare-Earth Nanoparticles for High-Resolution In Vivo Imaging at NIR IIb/c Window.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41129415.
- Also identified by DOI 10.1021/acs.nanolett.5c04506.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rare-earth nanoparticles (RENPs) operating in the NIR-IIb/c (1600-2000 nm) window hold great promise for bioimaging due to superior spatial resolution and deep tissue penetration. However, achieving high-brightness RENPs with precise emission control remains a significant challenge. Here, we report the rational design of highly Tm<sup>3+</sup>-doped α-phase core@shell@shell@shell RENPs with a cascade Nd<sup>3+</sup>-sensitized energy transfer architecture. Optimized RENPs exhibited a quantum yield (QY) of ∼23.5% in the NIR-IIb/c region under 980 nm excitation and achieved a QY of ∼11.3% under 808 nm excitation. Notably, the emission efficiency of highly Tm<sup>3+</sup>-doped systems (≥8%) is strongly dependent on the thickness of the intermediate Yb<sup>3+</sup> shell, while low Tm<sup>3+</sup> doping levels (≤4%) show minimal sensitivity to shell thickness. Furthermore, the engineered RENPs exhibit excellent biocompatibility and enable high-contrast deep-tissue vascular imaging in vivo. Our work provides a promising strategy for developing next-generation RENPs tailored for high-performance, noninvasive NIR-IIb/c bioimaging applications.
Medical subject headings
- Nanoparticles
- Metals, Rare Earth
- Optical Imaging